Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)

NACompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

November 30, 2013

Conditions
Pulmonary ComplicationsHIV Infections
Interventions
OTHER

Smoking Cessation

"A Motivational Interview session (\~40-50 minutes) will be delivered by a trained nurse coordinator.~Treatment with varenicline (1 mg daily during week 1 (pre-quit week) followed by 1 mg twice daily for weeks 2-12)or nicotine replacement therapy (21 mg of a skin patch + nicotine gum 4 mg ad lib added for breakthrough craving up to 20 pieces/day."

Trial Locations (1)

43210

Ohio State University, Columbus

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

collaborator

New York University

OTHER

collaborator

Ohio State University

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

University of Washington

OTHER

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00933595 - Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) | Biotech Hunter | Biotech Hunter